设计人类干预研究,预防膝关节损伤后的骨关节炎:跨学科 OARSI 2023 研讨会报告

Jackie L. Whittaker , Raneem Kalsoum , James Bilzon , Philip G. Conaghan , Kay Crossley , George R. Dodge , Alan Getgood , Xiaojuan Li , Elena Losina , Deborah J. Mason , Brian Pietrosimone , May Arna Risberg , Frank Roemer , David Felson , Adam G. Culvenor , Duncan Meuffels , Nicole Gerwin , Lee S. Simon , L. Stefan Lohmander , Martin Englund , Fiona E. Watt
{"title":"设计人类干预研究,预防膝关节损伤后的骨关节炎:跨学科 OARSI 2023 研讨会报告","authors":"Jackie L. Whittaker ,&nbsp;Raneem Kalsoum ,&nbsp;James Bilzon ,&nbsp;Philip G. Conaghan ,&nbsp;Kay Crossley ,&nbsp;George R. Dodge ,&nbsp;Alan Getgood ,&nbsp;Xiaojuan Li ,&nbsp;Elena Losina ,&nbsp;Deborah J. Mason ,&nbsp;Brian Pietrosimone ,&nbsp;May Arna Risberg ,&nbsp;Frank Roemer ,&nbsp;David Felson ,&nbsp;Adam G. Culvenor ,&nbsp;Duncan Meuffels ,&nbsp;Nicole Gerwin ,&nbsp;Lee S. Simon ,&nbsp;L. Stefan Lohmander ,&nbsp;Martin Englund ,&nbsp;Fiona E. Watt","doi":"10.1016/j.ocarto.2024.100449","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The global impact of osteoarthritis is growing. Currently no disease modifying osteoarthritis drugs/therapies exist, increasing the need for preventative strategies. Knee injuries have a high prevalence, distinct onset, and strong independent association with post-traumatic osteoarthritis (PTOA). Numerous groups are embarking upon research that will culminate in clinical trials to assess the effect of interventions to prevent knee PTOA despite challenges and lack of consensus about trial design in this population. Our objectives were to improve awareness of knee PTOA prevention trial design and discuss state-of-the art methods to address the unique opportunities and challenges of these studies.</p></div><div><h3>Design</h3><p>An international interdisciplinary group developed a workshop, hosted at the 2023 Osteoarthritis Research Society International Congress. Here we summarize the workshop content and outputs, with the goal of moving the field of PTOA prevention trial design forward.</p></div><div><h3>Results</h3><p>Workshop highlights included discussions about target population (considering risk, homogeneity, and possibility of modifying osteoarthritis outcome); target treatment (considering delivery, timing, feasibility and effectiveness); comparators (usual care, placebo), and primary symptomatic outcomes considering surrogates and the importance of knee function and symptoms other than pain to this population.</p></div><div><h3>Conclusions</h3><p>Opportunities to test multimodal PTOA prevention interventions across preclinical models and clinical trials exist. As improving symptomatic outcomes aligns with patient and regulator priorities, co-primary symptomatic (single or aggregate/multidimensional outcome considering function and symptoms beyond pain) and structural/physiological outcomes may be appropriate for these trials. To ensure PTOA prevention trials are relevant and acceptable to all stakeholders, future research should address critical knowledge gaps and challenges.</p></div>","PeriodicalId":74377,"journal":{"name":"Osteoarthritis and cartilage open","volume":"6 2","pages":"Article 100449"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2665913124000165/pdfft?md5=6f50c58e056dcf0e2bddb41e974a816e&pid=1-s2.0-S2665913124000165-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Toward designing human intervention studies to prevent osteoarthritis after knee injury: A report from an interdisciplinary OARSI 2023 workshop\",\"authors\":\"Jackie L. Whittaker ,&nbsp;Raneem Kalsoum ,&nbsp;James Bilzon ,&nbsp;Philip G. Conaghan ,&nbsp;Kay Crossley ,&nbsp;George R. Dodge ,&nbsp;Alan Getgood ,&nbsp;Xiaojuan Li ,&nbsp;Elena Losina ,&nbsp;Deborah J. Mason ,&nbsp;Brian Pietrosimone ,&nbsp;May Arna Risberg ,&nbsp;Frank Roemer ,&nbsp;David Felson ,&nbsp;Adam G. Culvenor ,&nbsp;Duncan Meuffels ,&nbsp;Nicole Gerwin ,&nbsp;Lee S. Simon ,&nbsp;L. Stefan Lohmander ,&nbsp;Martin Englund ,&nbsp;Fiona E. Watt\",\"doi\":\"10.1016/j.ocarto.2024.100449\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>The global impact of osteoarthritis is growing. Currently no disease modifying osteoarthritis drugs/therapies exist, increasing the need for preventative strategies. Knee injuries have a high prevalence, distinct onset, and strong independent association with post-traumatic osteoarthritis (PTOA). Numerous groups are embarking upon research that will culminate in clinical trials to assess the effect of interventions to prevent knee PTOA despite challenges and lack of consensus about trial design in this population. Our objectives were to improve awareness of knee PTOA prevention trial design and discuss state-of-the art methods to address the unique opportunities and challenges of these studies.</p></div><div><h3>Design</h3><p>An international interdisciplinary group developed a workshop, hosted at the 2023 Osteoarthritis Research Society International Congress. Here we summarize the workshop content and outputs, with the goal of moving the field of PTOA prevention trial design forward.</p></div><div><h3>Results</h3><p>Workshop highlights included discussions about target population (considering risk, homogeneity, and possibility of modifying osteoarthritis outcome); target treatment (considering delivery, timing, feasibility and effectiveness); comparators (usual care, placebo), and primary symptomatic outcomes considering surrogates and the importance of knee function and symptoms other than pain to this population.</p></div><div><h3>Conclusions</h3><p>Opportunities to test multimodal PTOA prevention interventions across preclinical models and clinical trials exist. As improving symptomatic outcomes aligns with patient and regulator priorities, co-primary symptomatic (single or aggregate/multidimensional outcome considering function and symptoms beyond pain) and structural/physiological outcomes may be appropriate for these trials. To ensure PTOA prevention trials are relevant and acceptable to all stakeholders, future research should address critical knowledge gaps and challenges.</p></div>\",\"PeriodicalId\":74377,\"journal\":{\"name\":\"Osteoarthritis and cartilage open\",\"volume\":\"6 2\",\"pages\":\"Article 100449\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2665913124000165/pdfft?md5=6f50c58e056dcf0e2bddb41e974a816e&pid=1-s2.0-S2665913124000165-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Osteoarthritis and cartilage open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2665913124000165\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Osteoarthritis and cartilage open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2665913124000165","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目标骨关节炎对全球的影响与日俱增。目前还没有改变疾病的骨关节炎药物/疗法,因此更需要预防性策略。膝关节损伤具有发病率高、起病明显、与创伤后骨关节炎(PTOA)密切相关等特点。尽管对这一人群的试验设计存在挑战且缺乏共识,但许多研究小组仍在着手开展研究,最终将通过临床试验来评估预防膝关节骨关节炎的干预措施的效果。我们的目标是提高对膝关节PTOA预防试验设计的认识,并讨论最先进的方法来应对这些研究的独特机遇和挑战。设计一个国际跨学科小组在2023年骨关节炎研究学会国际大会期间举办了一次研讨会。在此,我们总结了研讨会的内容和成果,旨在推动 PTOA 预防试验设计领域的发展。结果研讨会重点讨论了目标人群(考虑风险、同质性和改变骨关节炎结果的可能性);目标治疗(考虑给药、时间、可行性和有效性);比较对象(常规护理、安慰剂)和主要症状结果(考虑替代物和膝关节功能以及疼痛以外症状对该人群的重要性)。由于改善症状结果符合患者和监管机构的优先考虑事项,这些试验可能适合采用共同主要症状(单一或综合/多维结果,考虑疼痛以外的功能和症状)和结构/生理结果。为确保 PTOA 预防试验与所有利益相关者相关并为其所接受,未来的研究应解决关键的知识差距和挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Toward designing human intervention studies to prevent osteoarthritis after knee injury: A report from an interdisciplinary OARSI 2023 workshop

Objective

The global impact of osteoarthritis is growing. Currently no disease modifying osteoarthritis drugs/therapies exist, increasing the need for preventative strategies. Knee injuries have a high prevalence, distinct onset, and strong independent association with post-traumatic osteoarthritis (PTOA). Numerous groups are embarking upon research that will culminate in clinical trials to assess the effect of interventions to prevent knee PTOA despite challenges and lack of consensus about trial design in this population. Our objectives were to improve awareness of knee PTOA prevention trial design and discuss state-of-the art methods to address the unique opportunities and challenges of these studies.

Design

An international interdisciplinary group developed a workshop, hosted at the 2023 Osteoarthritis Research Society International Congress. Here we summarize the workshop content and outputs, with the goal of moving the field of PTOA prevention trial design forward.

Results

Workshop highlights included discussions about target population (considering risk, homogeneity, and possibility of modifying osteoarthritis outcome); target treatment (considering delivery, timing, feasibility and effectiveness); comparators (usual care, placebo), and primary symptomatic outcomes considering surrogates and the importance of knee function and symptoms other than pain to this population.

Conclusions

Opportunities to test multimodal PTOA prevention interventions across preclinical models and clinical trials exist. As improving symptomatic outcomes aligns with patient and regulator priorities, co-primary symptomatic (single or aggregate/multidimensional outcome considering function and symptoms beyond pain) and structural/physiological outcomes may be appropriate for these trials. To ensure PTOA prevention trials are relevant and acceptable to all stakeholders, future research should address critical knowledge gaps and challenges.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Osteoarthritis and cartilage open
Osteoarthritis and cartilage open Orthopedics, Sports Medicine and Rehabilitation
CiteScore
3.30
自引率
0.00%
发文量
0
期刊最新文献
Editorial Board Contents MicroRNA-181a/b-1 enhances chondroprogenitor anabolism and downregulates aquaporin-9 Safety and preliminary efficacy of transcutaneous auricular vagus nerve stimulation on chronic knee pain: A pilot trial Study protocol for the PICASSO trial: A randomized placebo-controlled trial to investigate the efficacy and safety of intraarticular steroid injections and an occupational therapy intervention in painful inflammatory carpometacarpal-1 osteoarthritis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1